fsockopen(): unable to connect to ssl://query.yahooapis.com:443 (php_network_getaddresses: getaddrinfo failed: Name or service not known)
The next-generation colonoscopy device, the ‘Fuse’, was presented for the first time at an international conference recently held at Rambam. This innovation can detect a 30% broader range of polyps than can existing devices.

The 12th meeting of the international workshop, LIVE ISRAEL ENDOSCOPY 2013, was held recently at Rambam and the Faculty of Medicine of the Technion – Israel Institute of Technology. In attendance were the world’s top gastroenterologists, who deal with early detection of gastrointestinal diseases. The workshop was organized by Dr. Alain Suissa, director of Rambam’s Unit of Gastroenterology Ambulatory Care, together with Prof. Ian Gralnek and Dr. Iyad Khamaysi, both senior physicians at the Institute of Gastroenterology at Rambam, which is directed by Prof. Yehuda Chowers. At the event, leading doctors from Europe and the USA conducted advanced and complicated endoscopic procedures. Performed at the ERCP Institute at Rambam’s X-ray Unit, the procedures were broadcast live at the institute’s Ruth Auditorium.

As part of the workshop, the ‘Fuse’, a device expected to become the ‘star’ of colonoscopy worldwide, was presented.
The ‘Fuse’ is a new product of the American company, Endo Choice, which based it on an Israeli development acquired
from the Israeli start-up firm, Peer Medical. 

Dr. Alain Suissa performing the use of the ‘Fuse’ during an international conference recently held at Rambam
Photo credit: Erez Kuriel - Point 2 Point

During a colonoscopy, an endoscope (a flexible tube with a camera at the end) is inserted into the patient’s colon. In this procedure, which is considered crucial for the early detection of colon cancer, the doctor seeks polyps and tumors.

 Standard endoscope technology used today is almost 30 years old. Currently, the device’s camera, fixed at the end of the scope, provides a field of vision of 170 degrees.

The Israeli development adds two side cameras that offer a 330 degree field of vision to the narrow, flexible tube. In other words, where conventional methods allow doctors to see only what is occurring right in front of them, the Fuse provides a view of the colon’s sides, as well. In a project comprising a number of leading international medical research experiments, polyps were ‘transplanted’ into a model of a colon. Doctors were asked to find these polyps with the new technology. Prof Ian Gralnek, who was among the leading testers, said that the new device, with its increased field of vision, identified close to 86% of the polyps in the colon, in contrast to 54% with the standard device used today. “This represents a revolution in the ability to identify polyps and tumors,” says Prof Gralnek. He added that doctors who use the new device in the future will have to get used to viewing three separate screens – one for each camera – simultaneously.